WINTON GROUP Ltd lowered its stake in shares of Albemarle Co. (NYSE:ALB) by 10.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,748 shares of the specialty chemicals company’s stock after selling 534 shares during the period. WINTON GROUP Ltd’s holdings in Albemarle were worth $647,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ALB. Baillie Gifford & Co. raised its position in Albemarle by 100.8% in the second quarter. Baillie Gifford & Co. now owns 184,555 shares of the specialty chemicals company’s stock valued at $19,478,000 after purchasing an additional 92,650 shares during the period. Meiji Yasuda Asset Management Co Ltd. purchased a new stake in shares of Albemarle in the 2nd quarter valued at $439,000. Lord Abbett & CO. LLC purchased a new stake in shares of Albemarle in the 2nd quarter valued at $11,681,000. Sumitomo Life Insurance Co. purchased a new stake in shares of Albemarle in the 3rd quarter valued at $1,703,000. Finally, Vanguard Group Inc. raised its holdings in shares of Albemarle by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 12,501,329 shares of the specialty chemicals company’s stock valued at $1,319,389,000 after buying an additional 213,530 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Several equities research analysts recently issued reports on the company. Jefferies Group boosted their price objective on Albemarle from $156.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, November 14th. Deutsche Bank downgraded Albemarle from a “buy” rating to a “hold” rating in a report on Tuesday, November 14th. Robert W. Baird reiterated a “hold” rating and issued a $135.00 price objective on shares of Albemarle in a report on Wednesday, November 1st. Royal Bank Of Canada boosted their price objective on Albemarle from $149.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, November 10th. Finally, Nomura boosted their price objective on Albemarle to $159.00 and gave the company an “outperform” rating in a report on Friday, November 10th. Ten research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $128.45.

Albemarle Co. (NYSE:ALB) opened at $127.48 on Thursday. The stock has a market capitalization of $14,142.33, a PE ratio of 31.68, a PEG ratio of 1.94 and a beta of 1.69. Albemarle Co. has a 1 year low of $85.60 and a 1 year high of $144.99. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.01. The business had revenue of $755.00 million during the quarter, compared to analysts’ expectations of $732.19 million. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. The business’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 EPS. equities research analysts predict that Albemarle Co. will post 4.46 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be given a $0.32 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.00%. Albemarle’s dividend payout ratio (DPR) is presently 16.56%.

COPYRIGHT VIOLATION WARNING: This news story was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://theolympiareport.com/2017/12/07/winton-group-ltd-sells-534-shares-of-albemarle-co-alb.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.